广东专家指出，造血干细胞移植术后规范管理是患者生存关键

Core Viewpoint - Standardized management of hematopoietic stem cell transplantation is crucial for improving long-term quality of life for patients [1][2] Group 1: cGVHD Management - Chronic graft-versus-host disease (cGVHD) affects 30% to 70% of patients who undergo allogeneic hematopoietic stem cell transplantation, impacting multiple organs and tissues [1] - cGVHD is a leading cause of mortality among long-term complications of hematopoietic stem cell transplantation, necessitating comprehensive care [1] - More than half of cGVHD patients require second-line or later treatments after first-line standard therapy, with new targeted drugs emerging in recent years [1] Group 2: Healthcare Innovations - The first follow-up outpatient clinic for hematopoietic stem cell transplantation has been established in Guangdong Province, focusing on cGVHD management through a comprehensive early screening, diagnosis, and treatment system [2] - This new model aims to provide continuous and standardized medical support for patients post-transplant, potentially setting a precedent for future management of transplantation [2]